FDA-Approved Crystalline Polymorph Psilocybin Use

Document formatting and layout were reorganized with new page headers, reading dates, and committee assignments reflecting Senate processing.

Removed signature block placeholders and certification notes that were present in the House version but not needed in the Senate reorganized version.

Added Senate-specific reading dates and formatting indicating the bill passed third reading unamended in the Senate.

Corrected a typographical error where 'TI' was changed to 'THAT' in the definition of crystalline polymorph psilocybin to ensure accurate legal language.

Added standard legislative signatures and approval lines for the Speaker of the House, President of the Senate, Chief Clerk of the House, Secretary of the Senate, and Governor, indicating the bill has been enacted.

Removed draft annotations and placeholder text that were present in the unsigned version of the bill.

Added Senator Hinrichsen to the list of Senate sponsors alongside Senator Michaelson Jenet.

Updated the legislative declaration to include specific clinical trial data showing psilocybin significantly reduces depression scores compared to active placebos.

Removed the 'First Regular Session' and 'Seventy-fifth General Assembly' header text and replaced with updated sponsorship format.

Adjusted formatting of the bill title and summary section to reflect reengrossed status with all amendments included.

Added additional co-sponsors to the House sponsorship list: Bacon, Boesenecker, Camacho, Carter, Duran, Lindsay, McCormick, Phillips, Rutinel, Smith, Stewart R., Valdez, Woodrow, and Zokaie.

Updated the bill summary header to indicate it is now in the '3rd Reading Unamended' state with a new date of January 23, 2025, and removed the note about subsequent amendments.

Added 'ENGROSSED' header and '2nd Reading Unamended' stamp to indicate the bill's procedural status after House approval.

Removed 'INTRODUCED' header and removed bill number formatting from page headers (changed 'HB25-1063' to '1063').